EUROEYES (01846) announced that the group performed a total of 6,807 ophthalmic surgeries in the third quarter of 2025, representing an increase of approximately 5.6% compared to the same period in 2024 (6,445 surgeries as of September 30, 2024). The growth was primarily driven by a rise in lens replacement surgeries and the recovery of laser surgery volumes. This positive trend reflects growing patient demand in Q3 2025, contributing to improved overall performance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments